A detailed history of Chilton Capital Management LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Chilton Capital Management LLC holds 10,521 shares of ABT stock, worth $1.07 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
10,521
Previous 10,926 3.71%
Holding current value
$1.07 Million
Previous $1.2 Million 0.58%
% of portfolio
0.06%
Previous 0.06%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

SELL
$109.52 - $120.96 $44,355 - $48,988
-405 Reduced 3.71%
10,521 $1.2 Million
Q4 2023

Jan 18, 2024

BUY
$90.19 - $110.4 $10,732 - $13,137
119 Added 1.1%
10,926 $1.2 Million
Q3 2023

Nov 14, 2023

SELL
$95.53 - $114.62 $65,246 - $78,285
-683 Reduced 5.94%
10,807 $1.05 Million
Q2 2023

Aug 14, 2023

SELL
$100.78 - $112.29 $128,595 - $143,282
-1,276 Reduced 10.0%
11,490 $1.25 Million
Q1 2023

May 15, 2023

SELL
$96.86 - $114.01 $89,789 - $105,687
-927 Reduced 6.77%
12,766 $1.29 Million
Q4 2022

Feb 14, 2023

SELL
$95.06 - $111.52 $36,788 - $43,158
-387 Reduced 2.75%
13,693 $1.5 Million
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $27,286 - $31,592
-282 Reduced 1.96%
14,080 $1.36 Million
Q1 2022

May 16, 2022

BUY
$114.02 - $139.04 $17,331 - $21,134
152 Added 1.07%
14,362 $1.7 Million
Q4 2021

Feb 14, 2022

BUY
$115.53 - $141.46 $271,379 - $332,289
2,349 Added 19.8%
14,210 $2 Million
Q3 2021

Nov 04, 2021

BUY
$116.66 - $129.06 $120,043 - $132,802
1,029 Added 9.5%
11,861 $1.4 Million
Q2 2021

Aug 16, 2021

SELL
$105.79 - $124.53 $740 - $871
-7 Reduced 0.06%
10,832 $1.26 Million
Q1 2021

May 12, 2021

BUY
$108.84 - $128.23 $269,270 - $317,241
2,474 Added 29.58%
10,839 $1.3 Million
Q3 2020

Nov 13, 2020

BUY
$91.64 - $111.29 $766,568 - $930,940
8,365 New
8,365 $910,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $178B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Chilton Capital Management LLC Portfolio

Follow Chilton Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chilton Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chilton Capital Management LLC with notifications on news.